VT
GSK icon

Vise Technologies’s GSK GSK Stock Holding History

Vise Technologies’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09M Hold
42,671
– – 0.04% 352
2025
Q4 		$2.09M Buy
42,671
+11,313
+36% +$528K 0.04% 353
2025
Q3 		$1.35M Sell
31,358
-38,110
-55% -$1.49M 0.05% 349
2025
Q2 		$2.67M Buy
+69,468
New +$2.65M 0.11% 198
2024
Q4 		$1.3M Sell
38,419
-5,444
-12% -$196K 0.11% 198
2024
Q3 		$1.79M Buy
43,863
+5,879
+15% +$241K 0.23% 93
2024
Q2 		$1.46M Buy
37,984
+2,500
+7% +$105K 0.26% 87
2024
Q1 		$1.52M Buy
35,484
+1,957
+6% +$80.7K 0.3% 80
2023
Q4 		$1.24M Buy
33,527
+782
+2% +$28.1K 0.27% 88
2023
Q3 		$1.19M Buy
32,745
+672
+2% +$23.9K 0.29% 88
2023
Q2 		$1.14M Buy
32,073
+3,044
+10% +$109K 0.28% 84
2023
Q1 		$1.03M Buy
29,029
+2,778
+11% +$97.2K 0.27% 83
2022
Q4 		$922K Buy
26,251
+3,971
+18% +$132K 0.29% 81
2022
Q3 		$656K Buy
+22,280
New +$844K 0.25% 93
2022
Q2 		– Sell
-11,334
Closed -$617K – 305
2022
Q1 		$617K Buy
+11,334
New +$616K 0.23% 105

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vise Technologies's GSK Position: Q1 2026 in Review

Vise Technologies held its GSK (GSK) position steady in Q1 2026 at 42,671 shares worth $2.09M. The position accounts for 0.04% of the portfolio, ranked #352.

Vise Technologies first reported a position in GSK in Q1 2022 and has held it in 15 quarters since. The position peaked at $2.67M in Q2 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Vise Technologies held 42,671 shares of GSK worth $2.09M as of Q1 2026.
  • Vise Technologies left its GSK share count unchanged in Q1 2026.
  • GSK made up 0.04% of Vise Technologies's portfolio in Q1 2026, its #352 holding.
  • Vise Technologies first reported a position in GSK in Q1 2022 and has held it in 15 quarters since.
  • Vise Technologies's GSK position peaked at $2.67M in Q2 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.